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ABSTRACT 
People suffer dysphagia when swallowing hard tablets and capsules. Gelatin based soft 
chewable tablets was used as an alternative and novel drug delivery format to overcome dysphagia. 
But conventional method of producing gelatin based soft chewable tablets has many potential 
issues. The objective of this study is using glycerol and hot-melt extrusion technique to address 
potential issues and optimizing the formulation. Gelatin (15%), acetaminophen (30%), saccharin 
(1.5%), xylitol (6.5%), sodium chloride (2%) and six different ratios of water (45-0%) and glycerol 
(0-45%) were used in seven formulations. The extrusion process temperature of formulation 1-6 
and formulation 7 were 90 ˚C and 140 ˚C, respectively.  Near-infrared spectra were collected 
during extrusion to monitor the quality consistency. Scanning electronic microscopy images of 
tablets’ cross-section were taken by JOEL model SEM. Differential scanning calorimetry was used 
to characterize the crystal states of each formulation. Texture profile analysis test was used to 
evaluate the physical properties of tables. In vitro drug release was conducted by using a USP-II 
dissolution apparatus. 45 days’ stability studies were carried out to evaluate the stability of each 
formulation. Near-infrared spectra showed that formulation 1-6 were uniform and formulation 7 
was not uniform and different with the others. From differential scanning calorimetry results, 
formulation 1 and 2 had crystal of acetaminophen. In drug content experiment, formulation 1 was 
most inaccurate and formulation 6 is most accurate. Formulation 5 had best physical and chemical 
stability in texture profile analysis and in vitro drug release studies. Using glycerol and hot-melt 
extrusion successfully addressed the potential issues of conventional method. Formulation 5 is the 
best formulation in seven formulations. 
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INTRODUCTION 
Oral delivery is generally considered as the safest and most practical drug delivery route 
for Pharmaceuticals(Aulton and Taylor 2013) However, some of the patients, especially pediatric 
and geriatric population, suffer dysphagia when swallowing tablets or capsules through traditional 
oral administration. (Dille, Hattrem, and Draget 2017; Liu et al. 2014), In order to solve the 
problem, patients usually try to crush or break hard tablets and swallow them with food or water. 
However, in this way, the extent or rate of drug released and absorption of the active 
pharmaceutical ingredient (API) may be changed after breaking tablets(Liu et al. 2014; Manmohan 
et al. n.d.). In addition, broken tablets will result in inaccuracy of dosing (Liu et al. 2014)which 
may lead to more hospitalization, health care costs and deaths(Manmohan et al. n.d.). 
To overcome the dysphagia, chewable formulations have been developed where the API 
kept s within a soft matrix during storage and mastication(Dille, Hattrem, and Draget 2017). 
Compared to gels made with other gelling agents such as starch or pectin, using gelatin for the soft 
chewable dose is likely to be an optimal choice because of gelatin’s ease of use, availability and 
excellent properties in regards to texture, dissolution profile and transition temperature(Karim and 
Bhat 2008; Morrison et al. 1999). Jelly and gummy candies and desserts based on gelatin have 
been widely applied in the food industry, indicating gelatin gels are generally well accepted among 
all age groups(Djagny, Wang, and Xu 2001; Morrison et al. 1999). Since melting temperature of 
gelatin gel is similar to human body’s temperature, gelatin gel can dissolve in the gastrointestinal 
tract 
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rapidly, which is very important for consistent and superior bioavailability of soft chewable 
dose. It shows the promising future of gels applied in pharmaceutical products developments. 
Traditional and widely used preparation of soft-chews is solvent evaporation which is 
dissolving gel agents, API, and other agents such as sweetener, taste-masking agents in water while 
stirring, then homogenized solution became gel after water evaporation. Although gelatin-based 
soft-chews have been widely accepted by patients, the problems of long-term stability, accurate 
dosing and the quality consistency between batches still need to be addressed. In this work, 
glycerol and hot-melt extrusion (HME) technique were used to overcome the potential issues 
mentioned above. The glycerol has been widely developed and used in pharmaceuticals as a 
plasticizer to improve the elasticity of gelatin(Kavoosi, Dadfar, and Purfard 2013). Glycerol has 
excellent biological properties such as bioresorbability, biocompatibility, and non-
cytotoxicity(Carmona and Freedland 1989; Pisani et al. 2010). LD50 value of glycerol in rats was 
27,200mg/kg and 24,000mg/kg reported by Hine and Bartsch, respectively(Bartsch et al. 1976; 
HINE et al. 1953). In other ways, gelatin is both soluble in water and glycerol(References et al. 
1996).  Glycerol is a good stabilizer for the soft chew dispersions because of preventing APAP 
from degradation. Glycerol helps maintain moisture and texture in food and drug industry, it 
controls water activity and prolongs shelf life in many applications(Pagliaro and Rossi 2008). It 
has been reported earlier that glycerol is a water structure enhancer by Timasheff(Timasheff 1998). 
Glycerol is also a kind of sweetener. It is 60% as sweet as sucrose and is classified by the U.S. 
FDA among the sugar alcohols as a caloric macronutrient(Pagliaro and Rossi 2008). 
Hot-melt extrusion (HME) was an established technology from the 1930s, then the 
application of HME expanded to the pharmaceutical industry at the 1970s.  In HME process, 
rotating screws drive the physical mixture above the melting temperature (Tm) and/or above the 
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glass transition (Tg). Therefore, a uniform mixture of APIs, polymers, and excipients are achieved. 
Compare to the conventional methods, HME has several advantages for producing soft chewable 
tablets. 1) HME can be operated as a continuous process, which can ensure optimal quality control, 
reduce processing time, save costs of temporary storage and easily scale up(Douroumis 2012). In 
addition, Using HME to produce soft-chews can achieve accurate process temperature and precise 
dosage during the extrusion process.  2) Soft-chews produced by HME have better content 
uniformity and uniform dispersion of fine particles, ensuring uniformity and stability at different 
pH and moisture levels.(Crowley et al. 2007; Douroumis 2012). 3) Moreover, inline processing 
analytical technology (PAT) tool can be easily implemented, and real-time monitoring becomes a 
possibility (Crowley et al. 2007) 
In view of so many advantages of using HME to produce soft-chews, however, based on 
the research we have done, there has no report showed using HME to produce soft-chew drug 
products so far. So the purpose of this project is to continuously produce gelatin-based soft-chew 
utilizing HME technology with in-line Near-infrared(NIR) monitoring as a PAT. In this study, 
seven different formulations of soft-chews were successfully produced. We carried out a series of 
physical, chemical characterization on these soft-chews. In addition, in vitro drug release study 
was also done. Then, based on the results of the experiments, the formulation optimization study 
was conducted. 
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MATERIAL AND METHODS 
Materials 
Acetaminophen (APAP) (Spectrum Chemicals, Gardena CA), a crystalline BCS I drug 
with a melting point of 169°-170°C, was selected as a model drug. Gelatin from porcine skin (gel 
strength 300, type A; Sigma-Aldrich, USA) was used as the gelling agent. Glycerin (lab grade; 
Ward’s Science, USA) and DI (deionized)water were chosen as the solvent. Saccharin (>98%; 
Sigma-Aldrich, USA) and xylitol (Spectrum Chemicals, Gardena CA) were selected as the 
sweetener. Sodium chloride (Fisher Chemical, USA) was used for taste masking.  
Formulations 
Based on the preliminary experiment, 55% solid phase and 45% w/w solvent (water & 
glycerol) was planned for extrusion. Seven different ratios of water and glycerol combinations 
were used to optimizing the formulation. Seven formulations and the extrusion conditions are 
listed in table 1. 
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Table 1. Seven different formulations. 
Formulations Process T 
(˚C) 
APAP 
w/w% 
Gelatin 
w/w% 
Water 
w/w% 
Glycerol 
w/w% 
Saccharin 
w/w% 
Xylitol 
w/w% 
NaCl 
w/w% 
F1 90 30 15 45 0 1.5 6.5 2 
F2 90 30 15 33.1 11.9 1.5 6.5 2 
F3 90 30 15 22.4 22.6 1.5 6.5 2 
F4 90 30 15 12.8 32.2 1.5 6.5 2 
F5 90 30 15 4.1 40.9 1.5 6.5 2 
F6 90 30 15 0 45 1.5 6.5 2 
F7 140 30 15 0 45 1.5 6.5 2 
 
Characterization of soft-chew properties 
Preparation of the physical mixtures  
Solid states physical mixtures were tumble-mixed using a MaxiblendTM (GlobePharma, 
New Brunswick, NJ, USA) at 25 rpm for 20 min. The liquid phase was mixed via in baker and 
stirring for 10 min at 60 rpm. 
Preparation of the soft-chew dosages 
A ThermoFisher Scientific Process 11 twin screw co-rotating extruder was used to prepare 
the soft chew dosages; a ThermoFisher Antaris II NIR with an in-line fiber optical probe was 
inserted into the die as a PAT tool to monitor the quality of the extrudates. Powder physical 
mixtures were fed into the extruder from zone 3 at 3.3 g/min using single screw feeder, while the 
liquid phase was injected into the barrel at 2.7g/min by a peristaltic pump. Other extrusion 
parameters are shown in the (Figure 1) below, and the screw speed was set at 75 rpm. Extrudates 
were poured into a silicone mold; final products were obtained after cooling down to the room 
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temperature (20˚C). Process parameters such as torque and die pressure, as well as the NIR 
spectrum were collected for the future analytical purpose. 
 
Figure 1.  Screw configuration and extrusion process parameters. 
NIR spectroscopy  
Diffuse reflectance NIR spectra were continuously collected non-invasively and in-line by 
during hot-melt extrusion using Fourier-Transform NIR spectrometer (Thermo Fisher Scientific, 
Nicolet Antaris II near-IR analyzer) equipped with an InGaAs detector, a quartz halogen lamp, 
and a fiber-optic probe which was mounted in the extrusion die. Spectra were collected evert the 
30s in the 1000-4000 cm-1 wavenumber region with a resolution of 16 cm-1 and averaged over 32 
scans. For each formulation, 20 spectra were recorded. NIR data analysis was performed by using 
the TQ Analyst (Version 9.4.45, Thermo Fisher Scientific)  
Assessment of tablet morphology 
The extruded soft-chewable tablets were split by force for scanning electronic microscopy 
(SEM) analysis. Cross-sectional images of the extruded soft-chewable tablets were taken using a 
JOEL model SEM. 
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Differential scanning calorimetry (DSC) 
All samples were prepared with TA aluminum pans and hermetic lids (Tzero) with an 
average sample mass of 5–10mg. Measurements were performed on a DSC 25 with a heating rate 
of 10 °C/min. 5 to 8 mg samples were hermetically sealed in an aluminum pan and heated from 40 
to 190 °C. Ultra-purified nitrogen was used as a purge gas with a flow rate of 50 ml/min for all the 
experiments. Data were collected and analyzed with TA Advantage software. All melting 
temperatures were reported as extrapolated onset unless otherwise stated. 
In Vitro drug release studies 
The drug release studies for seven soft-chew formulations were conducted to determine the 
release profiles and to find out possible differences between the formulations. In vitro drug release 
study was conducted using a USP dissolution apparatus II equipment (Hanson Research SR8plus 
station). Each experiment was carried out in triplicate in 900 mL phosphate buffered saline(PBS) 
as dissolution media (pH=7.4) at 37 ± 0.5 °C with paddle speed of 50 rpm for 180 minutes. 
Dissolution fluid (~1.5 mL) was taken from 5, 10, 15, 30, 60, 90, 120 and 180 min. The samples 
were completely dissolved in 180 min. Every sample’s amount of released APAP was analyzed 
by High-Performance Liquid Chromatography (HPLC) (Waters 600 series HPLC system) at the 
wavelength of 243 nm with the 1:1 water: methanol as mobile phase. 
Texture profile analysis (TPA) test  
TPA test was conducted in TA.XT2i texture analyzer (Texture Technologies Corp., 
Hamilton, MA/Stable Micro Systems, Godalming, Surrey, UK). The soft-chew was cut into oral 
size (12*12*8 mm), and each formulation was subjected to two compression cycles by TA-3 (25.4 
mm d) cylindrical probe. If the test objective is breaking up the food until it is suitable to swallow, 
then the strains used by all means test products approximate 66% to 80%, (Bourne 1982) 75% 
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strain was used in this study.  It is reported that females and males’ average bite-force ranges 
between 40 and 55 kg, respectively(Raadsheer et al. 1999). Soft-chews were compressed using the 
following conditions: pre-set speed 3.0 mm/s; test speed 4.0 mm/s; post-test speed 4.0 mm/s; target 
mode: strain; strain:75%; trigger type: auto (force); trigger force 150 g. Cohesiveness, springiness, 
chewiness, and resilience were extracted from the TPA data(Bourne 1982). All experiments in the 
test were performed in triplicates. 
Stability studies 
The chemical and physical stability of the soft chew dosage was investigated during 45 
days by qualifying the drug release and texture profile using HPLC and TA.XT2i texture analyzer. 
Every soft-chew formulation was stored at 25°C and 60% relative humidity in a sealed amber 
plastic bottle. Drug release study was conducted at day 1, 15, 30, 45. TPA test was conducted on 
day 1 and day 45. 
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RESULTS AND DISCUSSION 
Preparation of soft-chews using HME 
During the hot-melt extrusion process, the quality of the soft-chew dosage was 
predominated by the several process parameters such as screw design, screw speed, process 
temperature, feed rate and zone of liquid addition. Phase was injected form zone 2 instead of zone 
1 to protect the instrument from the liquid flowing backward. It has been proved that heating the 
gelatin-glycerol solutions up to 90 °C is optimal and do not change the chemical structure of 
gelatin(Morsy et al. 2017). In order to obtain the optimized formulation, two kneading blocks were 
used to applying high shear stress for mixing the solid phase with the liquid phase. The observed 
process torque and die pressure was low during the extrusion process of all formulations which 
indicating the excellent extrudability of the gelatin-based formulation. Parameters of feeding rate 
and screw speed were optimized based on preliminary studies. The temperature set-up for zone 3 
to zone 8 was 90 °C when F1-F6 were extruded, ensuring gelatin were optimally mixed with 
glycerol solution and avoiding reaching the boiling point of water. The extrudates of F1-F6 were 
white and opacity viscous liquid, indicating the mixture were not total melt or APAP was not 
dissolved into the matrix.  
Because of the presence of water, the extrusion was conducted below 100 °C. F6 and F7 
were water free, F7 was extruded at 140 °C to study the difference process temperature influence 
on the APAP crystallinity transformation. It was observed that the F7 extrudates turn to yellowish 
and transparent viscous liquid which indicating APAP was melted and dissolved in the matrix. 
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Extrudates became the gel, and the color changed from yellowish and transparent to opaque 
and white after extrudates cooling down to the room temperature. One week later, the color of F7 
is yellow and white which is not as uniform as the other formulations (Figure 2).  
 
Figure 2. The appearance of F7 (a) and F6 (b). 
DSC analysis  
 
Figure 3. DSC thermogram of each formulations and APAP. 
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According to the DSC results (Figure 3), pure APAP was characterized by a single 
endotherm peak representing its melting point at 168 °C. F1 had a slower peak at 151 °C, which 
means some APAP of F1 dispersed or dissolved in the gelatin gel matrix. F2 showed a very smooth 
peak at 146 °C, it probably because more APAP was dispersed or dissolved in the gelatin gel 
matrix. However, the peaks of F1 and F2 shifted approximately 17 °C and 22 °C, respectively, 
possibly due to interactions among APAP, gelatin, and solvent. F3-7 did not have obvious peak. 
This indicates that almost all APAP of F3-7 was dispersed or dissolved in the matrix. 
SEM analysis 
 
Figure 4. SEM images of the surfaces of each formulation in 45th day. 
According to the SEM result (Figure 4), each formulation was not very smooth on the 
surface because of the presence of particles; these particles may be APAP. Compared to the particle 
size of the 45th day between formulations, F1 is greater than F2 is greater than the other 
formulation. Compared F6 with F7, the particles on F7’s surface were scaled and bigger than F6. 
The results of SEM corresponds to the DSC in some extent, since the more APAP was dissolved 
or dispersed in the matrix, the smaller particles of APAP was shown in the soft-chews’ surface. 
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NIR analysis 
 
Figure 5. In-line collected NIR spectra during hot-melt extrusion of each formulation and APAP. 
 
Figure 6. NIR 2nd derivative spectra of each formulation and APAP. 
According to the in-line NIR spectra of F1 to F6 (Figure 5), the NIR spectra of different 
formulations were apparently different. However, the spectra of the same formulation almost 
overlapped, indicating that the uniformity of the same formulation was excellent. Compared the 
spectra of pure APAP with the other formulations, the peaks of F1-6 around the 7500-6500 cm-1 
shifted to low energy side. The peak’s signal of APAP at 6000 cm-1 was stronger than the 
formulations, which means APAP may be dissolved or dispersed into the gelatin matrix. Moreover, 
according to the NIR spectra, the signal of F1 was strongest, and F6 was weakest, indicating that 
APAP of F1 was least dissolved or dispersed into the matrix and F6 was most. The results of DSC 
were consistent with this conjecture. 
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Based on the second derivative of NIR spectra (Figure 6), with the ratio of water decreased, 
peaks shifted to low energy side, indicating there were interactions between the matrix, which may 
be because of the formation of the hydrogen bonds. Therefore, future characterization such as 
Raman spectroscopy or Solid-state NMR needs to be conducted to confirm the existence of the 
hydrogen bonds. 
NIR spectra (Figure 5) and their second derivative (Figure 6) show that the F7 was totally 
different with the other formulations and had a poor consistency, which manifested that the 
uniformity of F7 is bad and the interactions happened in F7 may be different with other 
formulations. 
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In vitro drug release studies 
 
Figure 7. The dissolution profile of each formulation during in the first day. 
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Table 2. Elimination rate constant (K) of every formulation during 45 days. 
Formulation 1 d1 d15 d30 d45 
K±SD 1.11±0.14 1.21±0.03 1.25±0.08 1.40±0.07 
Formulation 2 d1 d15 d30 d45 
K±SD 1.18±0.05 1.37±0.27 1.73±0.10 1.95±0.46 
Formulation 3 d1 d15 d30 d45 
K±SD 1.58±0.12 1.64±0.15 1.70±0.07 1.42±0.11 
Formulation 4 d1 d15 d30 d45 
K±SD 2.17±0.48 2.17±0.30 2.40±0.48 2.23±0.27 
Formulation 5 d1 d15 d30 d45 
K±SD 2.20±0.28 2.20±0.26 2.26±0.29 2.13±0.25 
Formulation 6 d1 d15 d30 d45 
K±SD 2.69±0.25 2.34±0.09 2.30±0.19 2.28±0.21 
Formulation 7 d1 d15 d30 d45 
K±SD 1.21±0.21 1.75±0.21 2.00±0.21 1.85±0.34 
 
 
Figure 8. Pictorial depiction of gelatin molecule in water and glycerol solutions. 
The in vitro dissolution profile of formulations accorded with first-order elimination 
kinetics, so the elimination rate constant (K) of each formulation during 45 days was calculated 
(Table 2).  
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The primary objective is to develop the fast release soft-chew formulations with, almost all 
formulations’ drug release beyond 90% after 120 minutes’ dissolution test without chewing 
(Figure 7).  
In general, dissolution rate increases with the ratio of glycerol are increasing. It has been 
reported that gelatin will form a hydrogen bond with water but will not form a hydrogen bond with 
gelatin(Sanwlani, Kumar, and Bohidar 2011). This has been shown in a cartoon in Figure 8. Based 
on this truth, the reason for the different dissolution rate may due to the formulation with water 
ratios means there is hydrogen bonds formation. During dissolution, hydrogen bonds need to be 
broken up and gelatin chains have to be relaxed and loosen thus the APAP can be released from 
the matrix and dissolving into the PBS. More hydrogen bonds mean more energy and time needed 
to break it up. Therefore, water molecules from the dissolution media forming hydrogen bonds 
with the matrix and may lower the drug releasing rates. On the other hand, glycerol is a water 
structure enhancer, which has been reported earlier works(Timasheff 1998). This can be explained 
by the fact that when one glycerol molecule replaces one water molecule, one hydrogen bond 
donor and four hydrogen bond acceptors are increased. It proves that glycerol form hydrogen bond 
with water more easily than water itself. In the formulation with a higher ratio of glycerol, there 
are more glycerol molecules without forming a hydrogen bond. During dissolution, these free 
glycerol molecules would form hydrogen bonds with water molecules in PBS solvent. Thus, free 
glycerol molecules may accelerate soft-chews dissolving and drug release from the matrix. 
According to the results of DSC and dissolution test, the crystal of APAP slowed the dissolution 
rate. 
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Figure 9. The dissolution profile of F5. 
 
Figure 10. The dissolution profile of F3 (a) and F6 (b). 
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Figure 11. The dissolution profile of F1 (a) and F2 (b). 
 
Figure 12. The dissolution profile of F4 (a) and F7 (b). 
Drug release profiles with changing the storage time during 45 days’ storage period, the 
formulation 5 with 4.1: 40.9 water: glycerol ratio was the most stable where four dissolution curves 
almost overlapped (Figure 9), and the K did not have significant difference during 45 days (p-
value > 0.05). The dissolution rates of F3 and F6 didn’t have significant difference during 45 days 
(p-value > 0.05), but the stability of F3 and F6 was not as good as F5 (Figure 10). The dissolution 
rate of F1and F2 gradually increased (Figure 10) and K of F1 and F2 were significantly different 
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during 45 days (p-value < 0.05). Dissolution curves of F4 (Figure 11a) almost coincided from 1 
day to 30 days, the dissolution rate accelerated and became fastest on the 45th days. The K of F4 
also showed that K of day 1 was not significantly different with day 15 and day 30 (p-value > 0.05) 
but significantly different with day 45(p-value < 0.05). The dissolution curve of F7 (Figure 11b) 
almost overlapped from 15 days to 45 days (p-value > 0.05) and the dissolution rate of F7 was 
slowest on the first day. It means the dissolution rate of F7 sudden changed between the first day 
and 15 days. The K of F7 also proved that. The reason may be that during the period from the first 
day to the 15th days, there were still some interactions that were not done. Therefore, the 
dissolution profile was highly consistent afterward, and the first day was very different from the 
15th day. The picture of F7 45 day’s transverse section shows that F7 is white in the middle, with 
a yellow shell on the outside. The reason why drug content of F7 decreased may be that some 
APAP on the surface peeled off during storage.  
Drug content studies 
Table 3. Drug content of each formulation during 45 days. 
  F1 F2 F3 F4 F5 F6 F7 
Percent % Average Average Average Average Average Average Average 
Day 1  38.76±0.12 35.97±0.34 33.83±0.23 33.35±0.47 33.11±0.24 31.64±0.25 32.99±0.49 
Day 15 38.60±0.47 35.66±0.65 33.50±0.46 32.60±0.30 33.26±0.39 31.70±0.18 32.20±0.74 
Day 30 38.38±0.42 35.88±0.81 33.24±0.19 32.27±0.32 33.09±0.22 31.81±0.17 31.51±0.93 
Day 45 38.54±0.34 36.46±0.74 33.13±0.39 32.02±0.12 33.26±0.21 31.86±0.58 31.33±0.23 
All 38.57±0.16 35.99±0.34 33.43±0.31 32.56±0.58 33.18±0.09 31.75±0.10 32.01±0.76 
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Figure 13.  Drug content of each formulation during 45 days. 
 
Figure 14. Linear fitting of the first day’s drug content and moisture content. 
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According to Table 3 and Figure 13, drug content increases with the ratio of water 
increasing. It can be explained that the formulation with a higher ratio of water will evaporate more 
water during extrusion. The evaporation of water during extrusion maybe the main reason of dose 
inaccuracy. Therefore, the first-day data was graphed out with a drug content of each formulation 
versus each formulation’s ratio of water (Figure 14). To determine the relationship between drug 
content and moisture content, and the relationship was linear (R2=0.953) in some extent. Hope this 
figure can give some guidance for the future similar experiments. Compared to the expected drug 
content (30%), F6 (31.75%) is the most accurate formulation, and F1 (38.57%) is the most 
inaccurate formulation.  During 45 days’ drug content experiments, all formulations were stable. 
Stabilities of formulation 5 and 6 are optimal. The standard deviation of F5 and F6 are ±0.09% 
and ±0.10%, respectively. The picture (Figure 15) of F7 45 day’s transverse section shows that F7 
is white in the middle, with a yellow shell on the outside. The reason why drug content of F7 
decreased may be that some APAP on the surface peeled off during storage. Compared with the 
drug content on the first day of F6 and F7, evaporation of glycerol will occur both at 90 and 140 °C, 
but evaporation of glycerol during extrusion under 140 °C was greater than 90 °C.  
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Figure 15. Transverse section of F7 in 45th day. 
 
TPA test analysis 
Table 4. TPA test of each formulation on the first day and 45th day. 
 Hardness (kg)  Chewiness (kg) Cohesiveness Springiness Resilience 
F1d1 17.97±3.66 6.81±1.66 0.50±0.02 0.74±0.02 0.23±0.02 
F1d45 26.78±3.97 6.26±0.22 0.47±0.03 0.43±0.07 0.26±0.02 
F2d1 24.15±3.72 11.29±2.14 0.56±0.02 0.83±0.00 0.28±0.01 
F2d45 29.29±1.89 9.97±0.84 0.48±0.01 0.61±0.08 0.26±0.02 
F3d1 32.93±4.63 18.58±2.53 0.63±0.01 0.89±0.00 0.37±0.01 
F3d45 36.38±0.94 23.51±3.73 0.61±0.03 0.80±0.08 0.37±0.01 
F4d1 39.08±3.14 23.23±2.31 0.67±0.01 0.89±0.01 0.39±0.02 
F4d45 42.24±2.24 31.75±3.31 0.69±0.07 0.89±0.10 0.47±0.07 
F5d1 44.56±3.25 24.62±2.49 0.62±0.01 0.88±0.01 0.42±0.01 
F5d45 46.07±0.71 33.64±5.84 0.71±0.08 0.91±0.05 0.50±0.06 
F6d1 33.21±4.79 17.44±2.73 0.58±0.02 0.91±0.02 0.36±0.02 
F6d45 35.85±1.27 22.46±2.68 0.71±0.02 0.89±0.06 0.40±0.01 
F7d1 25.12±0.78 3.75±1.09 0.31±0.04 0.48±0.06 0.17±0.02 
F7d45 30.53±0.63 9.42±0.22 0.37±0.03 0.51±0.04 0.24±0.02 
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Figure 16. Typical force-time texture profile. 
Since TPA test imitates the mouth’s biting action, it was usually called “two bites test.”  
Many textural parameters can be qualified just in one experiment. A typical force-time texture 
profile is shown in Figure 16. For each profile, five parameters were analyzed: hardness, chewiness, 
cohesiveness, springiness, and resilience (Table 4). The values of cohesiveness, springiness, and 
resilience are in the range of 0 to 1.   
Hardness is the peak force in the first compression (Equation 1). 
Hardness=F1 (1) 
Cohesiveness, which is related to the strength of the internal bonds in the tested materials, 
it can be calculated by the area (A2) under the second cycle divided by the area (A1) under the 
first cycle (Equation 2).  
Cohesiveness=
𝐴2
𝐴1
   (2) 
Springiness has been defined as the strength of the gum cell network. It was used to 
describe the how well a material physically springs back after the compression force was removed. 
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It can be calculated the distance (t2) of the second compression divided by the original 
compression distance (t1) (Equation 3).  
Springiness=
𝑡2
𝑡1
 (3) 
Chewiness is defined as the force required to chew a solid food until it is suitable for 
swallowing(Bourne 1982). Chewiness is a relative value that can only be used to compare a 
reference material to the control It can be calculated ad Hardness * Cohesiveness * Springiness 
(Equation 4). 
Chewiness=F1
𝐴2
𝐴1
𝑡2
𝑡1
 (4) 
Resilience is used to describe how well a product tries to regain its original height. 
Resilience can be measured with the first compression, but the post-test speed and test speed must 
be same. It can be calculated by the upstroke area under the first compression divided by the 
downstroke area under the first compression (Equation 5). 
Resilience=
𝐴4
𝐴3
 (5) 
Normal soft-chews are expected to have intermedium values for hardness, chewiness, 
cohesiveness, springiness, and resilience. Soft soft-chews are supposed to have low hardness, 
chewiness, cohesiveness, springiness, and resilience. The opposite is also expected for hard soft-
chews. Table 4 shows that, in the first and 45th day’s TPA test, the increased hardness, springiness, 
cohesiveness, chewiness and resilience were observed with an increase in the ratio of glycerol 
from 0 to 41.9%. However, when the ratio of glycerol increased from 41.9% to 45%, a decrease 
of these parameters was observed. This indicated that increasing the ratio of glycerol can increase 
the tendency of the soft-chews to resist deformation by the flat probe during the two compression 
cycles. Moreover, with the increase the ratio of glycerol, soft-chews gradually became hard soft-
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chews from soft soft-chews. It has been mentioned that glycerol will form hydrogen bonds with 
water in gelatin-glycerol solution(Timasheff 1998).  Therefore, the amount of “available glycerol-
free water” is reduced with increasing the ratio of glycerol due to preferential hydrogen bonding 
between water and glycerol molecules. This decreases the amount of water available to bind the 
protein for hydration. Therefore, the gelatin molecules tended to go into regions of “available 
glycerol-free water” where the local gelatin concentration increased considerably, leading to form 
stronger gels(Sanwlani, Kumar, and Bohidar 2011). This also may be the reason why F5 with 4.1% 
water was stronger than F6 without water. 
Compared the results of the first day with 45th day, the hardness of every formulation 
increased. Cohesiveness and resilience have not significantly changed. However, the springiness 
of F1 and F2 significantly decreased, while others were mainly unchanged. However, the increase 
of hardness became smaller with the increase the ratio of glycerol. This manifested that the texture 
profile of soft-chews was more stable with the ratio of glycerol increasing.  
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CONCLUSION 
The potential issues mentioned above were successfully addressed and seven different 
kinds of soft-chews were successfully produced by HME. The in vivo drug release drug study 
shows that the dose accuracy will increase when the ratio of glycerol increased. Also, increase of 
the ratio of glycerol helps more APAP dissolve or disperse into gelatin matrix, accelerates drug 
released rates and increases the physical stability of soft-chews. According to NIR spectra, the 
uniformity of F1 to F6 is good. Compared F6 with F7, the particles on F7’s surface were scaled 
and bigger than F6. NIR spectra of F7 showed that F7 was not uniform like other formulations. 
The dissolution rate of F7 was slower than F6 and significantly changed after the 15th day. 
However, the dissolution rate of F6 was fast and stable for 45 days. According to TPA test results, 
F6 was more like a kind of hard soft-chew formulation and stable. The cohesiveness, chewiness, 
and resilience of F7 were lowest in the seven formulations, indicating F7 was not chewable like 
other formulations. Moreover, the physical stability of F7 was not good. In this study, synthesizing 
the results of uniformity, dose accuracy, dissolution profile, physical and chemical stability. 
Increasing process temperature to 140 °C to produce soft-chews by HME was inadvisable. The F5 
with 4.1: 40.9 water: glycerol ratio was optimal for soft-chews. 
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